Distribution of Mood and Personality Characteristics and Their Influence on Treatment Compliance
1 other identifier
observational
200
1 country
1
Brief Summary
This study intends to investigate the personality and psychological characteristics of OSA patients using classical standard scales and obtain treatment information and adherence data through prospective follow-up to summarize the distribution characteristics of mood and personality characteristics of OSA patients and their influence on treatment adherence. A thorough understanding of OSA patient characteristics from the perspective of personality and psychological characteristics will be of great significance to the classification of OSA patients, precision treatment, and improving treatment compliance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 14, 2024
CompletedFirst Submitted
Initial submission to the registry
December 22, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2025
CompletedFirst Posted
Study publicly available on registry
August 3, 2025
CompletedAugust 3, 2025
July 1, 2025
11 months
December 22, 2024
July 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Eysenck Personality Questionnaire (EPQ)
This study adopted the classic short form of the Eysenck Personality Questionnaire - Revised (EPQ-R Short Scale) to assess individual personality traits across four dimensions: Psychoticism (P), Extraversion (E), Neuroticism (N), and Lie Scale (L). Each dimension consists of 12 items, with scores ranging from 0 to 12. Higher scores indicate a stronger presence of the corresponding trait. For example, a higher score on Neuroticism reflects greater emotional instability, while a higher score on Extraversion suggests a more outgoing and active personality
At baseline
Secondary Outcomes (1)
continuous positive airway pressure (CPAP) compliance
From CPAP initiation to the 3-month follow-up
Study Arms (2)
Obstructive sleep apnea (OSA)
dignosis OSA according to the sleep study (AHI\>=5)
non-OSA
dignosis OSA according to the sleep study (AHI \<5)
Interventions
Eligibility Criteria
* Patients with sleep disorders other than sleep disorders and respiratory disorders; * Patients with severe mental diseases (such as schizophrenia, bipolar disorder, paranoid mental disorders, mental retardation associated with mental disorders, mental disorders caused by epilepsy, schizoaffective disorders) and personality disorders; * Patients who are taking sleep-affecting medication. ④ Unable to cooperate with the relevant psychological scales for depression, anxiety, personality, and others. ⑤ Patients who have previously used or are being treated with a non-invasive ventilator. ⑥ Other serious somatic diseases or other conditions that may affect ventilator treatment are unsuitable for enrollment as assessed by the investigator.
You may qualify if:
- Age: 18\~70 years old
- Suspected OSA based on symptoms such as snoring, waking at night, daytime sleepiness, or requiring OSA screening due to related conditions; or confirmed OSA patients referred for sleep monitoring or CPAP pressure titration.
- Subjects are conscious, utterly independent in behavioral and cognitive ability, and able to answer questions independently;
- The patients gave informed consent to the study and cooperated with relevant treatment and evaluation.
You may not qualify if:
- Age below 18 or above 70 years old
- No symptoms suggestive of OSA and no need for OSA screening; or patients without confirmed OSA
- lacking full independence in behavior and cognitive ability, unable to answer questions independently
- Patients who did not give informed consent or were unwilling to cooperate with treatment and evaluation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Respiratory Department of Peking University First Hospital
Beijing, Beijing Municipality, 10034, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jing Ma
Peking University First Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator,
Study Record Dates
First Submitted
December 22, 2024
First Posted
August 3, 2025
Study Start
September 14, 2024
Primary Completion
August 1, 2025
Study Completion
August 1, 2025
Last Updated
August 3, 2025
Record last verified: 2025-07